Corient Private Wealth LP Takes Position in Humana Inc. $HUM

Corient Private Wealth LP purchased a new position in shares of Humana Inc. (NYSE:HUM) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 624,775 shares of the insurance provider’s stock, valued at approximately $10,441,000.

A number of other institutional investors and hedge funds have also modified their holdings of the business. BlackRock Inc. bought a new position in Humana in the second quarter valued at approximately $4,138,160,000. Pzena Investment Management LLC bought a new stake in shares of Humana during the 2nd quarter valued at $1,749,014,000. Capital International Investors raised its position in shares of Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after acquiring an additional 3,097,571 shares during the last quarter. Norges Bank acquired a new position in shares of Humana in the 4th quarter valued at $456,632,000. Finally, Wellington Management Group LLP boosted its position in shares of Humana by 4,481.7% in the 4th quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock worth $306,460,000 after purchasing an additional 1,170,387 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Performance

Shares of HUM opened at $386.92 on Friday. The firm has a market cap of $46.46 billion, a P/E ratio of 36.61, a PEG ratio of 2.20 and a beta of 0.72. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The firm’s 50 day moving average price is $385.60 and its two-hundred day moving average price is $288.47.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the prior year, the firm earned $6.27 earnings per share. The firm’s revenue was up 26.2% compared to the same quarter last year. On average, analysts forecast that Humana Inc. will post 9.12 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently commented on HUM. Evercore raised Humana from an “in-line” rating to an “outperform” rating and set a $480.00 price objective for the company in a research note on Wednesday, July 29th. HSBC lowered Humana to a “hold” rating in a research note on Thursday, July 30th. Morgan Stanley upgraded Humana from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $249.00 to $370.00 in a research report on Tuesday, August 4th. UBS Group initiated coverage on Humana in a research note on Thursday, July 30th. They issued a “buy” rating for the company. Finally, Seaport Research Partners downgraded shares of Humana to a “neutral” rating in a research report on Wednesday, May 20th. Fourteen analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Humana has a consensus rating of “Hold” and a consensus target price of $403.91.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.